Price to Earnings (P/E)
since 2005
Calculation
Bristol-Myers Squibb Co., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net earnings (loss) attributable to BMS1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | — | = | 60.00 | ÷ | -4.02 | -4.02 | = | -9,015 | ÷ | 2,240,475,153 | |
| Dec 31, 2019 | 41.99 | = | 63.97 | ÷ | 1.52 | 1.52 | = | 3,439 | ÷ | 2,257,510,796 | |
| Dec 31, 2018 | 16.81 | = | 50.65 | ÷ | 3.01 | 3.01 | = | 4,920 | ÷ | 1,632,675,877 | |
| Dec 31, 2017 | 103.55 | = | 63.87 | ÷ | 0.62 | 0.62 | = | 1,007 | ÷ | 1,632,582,502 | |
| Dec 31, 2016 | 20.56 | = | 54.78 | ÷ | 2.66 | 2.66 | = | 4,457 | ÷ | 1,672,715,340 | |
| Dec 31, 2015 | 64.22 | = | 60.20 | ÷ | 0.94 | 0.94 | = | 1,565 | ÷ | 1,669,459,090 | |
| Dec 31, 2014 | 49.80 | = | 60.04 | ÷ | 1.21 | 1.21 | = | 2,004 | ÷ | 1,662,118,446 | |
| Dec 31, 2013 | 35.01 | = | 54.37 | ÷ | 1.55 | 1.55 | = | 2,563 | ÷ | 1,650,232,566 | |
| Dec 31, 2012 | 30.56 | = | 36.58 | ÷ | 1.20 | 1.20 | = | 1,960 | ÷ | 1,637,354,662 | |
| Dec 31, 2011 | 15.07 | = | 33.12 | ÷ | 2.20 | 2.20 | = | 3,709 | ÷ | 1,688,107,071 | |
| Dec 31, 2010 | 13.99 | = | 25.49 | ÷ | 1.82 | 1.82 | = | 3,102 | ÷ | 1,702,427,438 | |
| Dec 31, 2009 | 4.03 | = | 24.95 | ÷ | 6.19 | 6.19 | = | 10,612 | ÷ | 1,714,140,539 | |
| Dec 31, 2008 | 7.68 | = | 20.37 | ÷ | 2.65 | 2.65 | = | 5,247 | ÷ | 1,979,509,306 | |
| Dec 31, 2007 | 20.60 | = | 22.53 | ÷ | 1.09 | 1.09 | = | 2,165 | ÷ | 1,979,387,706 | |
| Dec 31, 2006 | 34.64 | = | 27.19 | ÷ | 0.78 | 0.78 | = | 1,585 | ÷ | 2,019,481,440 | |
| Dec 31, 2005 | 14.96 | = | 22.91 | ÷ | 1.53 | 1.53 | = | 3,000 | ÷ | 1,959,073,035 |
Based on: 10-K (filing date: 2021-02-10), 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Bristol-Myers Squibb Co.’s Annual Report.
Comparison to Competitors
Bristol-Myers Squibb Co., P/E, long-term trends, comparison to competitors
| Bristol-Myers Squibb Co. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Eli Lilly & Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | — | 48.49 | 40.17 | 18.82 | 31.95 | — | 109.92 | 28.92 | 26.72 | 19.62 | 15.09 | 20.18 | 48.25 |
| Dec 31, 2019 | 41.99 | 41.83 | 17.82 | 17.07 | 16.19 | 16.45 | 43.43 | 25.99 | 20.60 | 11.63 | 19.86 | 52.90 | 45.89 |
| Dec 31, 2018 | 16.81 | 56.47 | 20.60 | 14.01 | 39.13 | 15.26 | 52.00 | 23.74 | 33.46 | 21.58 | 18.17 | 22.59 | 28.68 |
| Dec 31, 2017 | 103.55 | 220.29 | 35.47 | 64.06 | — | 22.75 | 44.63 | 268.10 | 61.63 | 9.99 | 28.99 | 155.08 | 44.09 |
| Dec 31, 2016 | 20.56 | 55.16 | 16.54 | 16.03 | 32.39 | 6.83 | 52.01 | 20.08 | 46.14 | 28.10 | 42.64 | — | 31.63 |
| Dec 31, 2015 | 64.22 | 12.83 | 17.01 | 15.95 | 33.35 | 6.75 | 50.07 | 18.80 | 31.64 | 26.37 | 60.50 | — | 62.14 |
| Dec 31, 2014 | 49.80 | 31.30 | 55.08 | 22.96 | 33.06 | 12.85 | 80.83 | 17.15 | 13.94 | 23.03 | 118.44 | — | 39.59 |
| Dec 31, 2013 | 35.01 | 23.25 | 19.64 | 18.69 | 13.88 | 42.00 | 174.33 | 18.72 | 37.83 | 9.32 | 77.00 | — | 29.02 |
| Dec 31, 2012 | 30.56 | 9.24 | 11.51 | 15.68 | 14.99 | 25.20 | 39.96 | 19.64 | 20.94 | 13.51 | 21.42 | — | 38.30 |
| Dec 31, 2011 | 15.07 | 18.67 | — | 14.61 | 10.42 | 12.20 | 72.33 | 18.48 | 18.63 | 15.99 | — | 267.42 | — |
| Dec 31, 2010 | 13.99 | 15.68 | — | 10.53 | 7.86 | 10.68 | 70.92 | 12.23 | 116.63 | 18.63 | — | — | — |
| Dec 31, 2009 | 4.03 | 14.69 | — | 12.10 | 9.18 | 16.29 | 60.45 | 14.22 | 9.00 | 16.41 | — | — | — |
| Dec 31, 2008 | 7.68 | 17.11 | — | 12.06 | — | 20.29 | 77.14 | 11.67 | 6.53 | 10.25 | — | — | — |
| Dec 31, 2007 | 20.60 | 23.82 | — | 15.64 | 19.26 | 25.19 | — | 17.07 | 29.88 | 18.51 | — | — | — |
| Dec 31, 2006 | 34.64 | 48.17 | — | 25.43 | 22.40 | — | 50.48 | 17.02 | 21.57 | 9.18 | — | — | — |
| Dec 31, 2005 | 14.96 | 20.03 | — | 23.70 | 31.90 | 34.15 | — | 16.95 | 16.62 | 23.92 | — | — | — |
Based on: 10-K (filing date: 2021-02-10), 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Bristol-Myers Squibb Co., P/E, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Bristol-Myers Squibb Co. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2020 | — | — |
| Dec 31, 2019 | 41.99 | 21.51 |
| Dec 31, 2018 | 16.81 | 23.71 |
| Dec 31, 2017 | 103.55 | 38.05 |
| Dec 31, 2016 | 20.56 | 21.33 |
| Dec 31, 2015 | 64.22 | 19.24 |
| Dec 31, 2014 | 49.80 | 21.98 |
| Dec 31, 2013 | 35.01 | 19.69 |
| Dec 31, 2012 | 30.56 | 16.80 |
| Dec 31, 2011 | 15.07 | 16.77 |
| Dec 31, 2010 | 13.99 | 16.01 |
| Dec 31, 2009 | 4.03 | 11.66 |
| Dec 31, 2008 | 7.68 | 12.77 |
| Dec 31, 2007 | 20.60 | 20.58 |
| Dec 31, 2006 | 34.64 | 18.29 |
| Dec 31, 2005 | 14.96 | 20.86 |
Based on: 10-K (filing date: 2021-02-10), 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).
Comparison to Industry (Health Care)
Bristol-Myers Squibb Co., P/E, long-term trends, comparison to industry (health care)
| Bristol-Myers Squibb Co. | Health Care | |
|---|---|---|
| Dec 31, 2020 | — | — |
| Dec 31, 2019 | 41.99 | 23.31 |
| Dec 31, 2018 | 16.81 | 25.51 |
| Dec 31, 2017 | 103.55 | 35.65 |
| Dec 31, 2016 | 20.56 | 22.95 |
| Dec 31, 2015 | 64.22 | 20.83 |
| Dec 31, 2014 | 49.80 | 22.58 |
| Dec 31, 2013 | 35.01 | 19.63 |
| Dec 31, 2012 | 30.56 | 17.46 |
| Dec 31, 2011 | 15.07 | 16.21 |
| Dec 31, 2010 | 13.99 | 16.26 |
| Dec 31, 2009 | 4.03 | 12.70 |
| Dec 31, 2008 | 7.68 | 14.16 |
| Dec 31, 2007 | 20.60 | 20.89 |
| Dec 31, 2006 | 34.64 | 20.98 |
| Dec 31, 2005 | 14.96 | 22.02 |
Based on: 10-K (filing date: 2021-02-10), 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12), 10-K (filing date: 2015-02-13), 10-K (filing date: 2014-02-14), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-17), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-22), 10-K (filing date: 2007-02-26), 10-K (filing date: 2006-03-14).